Track topics on Twitter Track topics that are important to you
CAMBRIDGE, Mass., June 4, 2015 (GLOBE NEWSWIRE) -- Metabolix, Inc. (Nasdaq:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, today announced it will be participating in two panel presentations during the HBA Global 2015 conference, a leading event highlighting innovations in the health and beauty sectors. During the panel sessions, Metabolix will present insights into how its PHA (polyhydroxyalkanoate polymers) biopolymer materials can enhance sustainability and performance in cosmetic and personal care ingredients and packaging applications. HBA Global is being held June 9-11 at the Jacob K. Javits Convention Center in New York City.
Metabolix is developing biobased PHA biopolymers that are biodegradeable in soil, fresh water, and marine environments. In addition, Metabolix's PHA enhances the property performance of polylactic acid (PLA), a leading biopolymer, including adding strength, toughness, and "softness" in certain packaging applications.
"Metabolix's Mirel® PHA material provides new options for creating new ingredients and packaging designs for the personal care market. The HBA Global conference is an excellent platform to share that knowledge with the industry," said Max Senechal, Metabolix's vice president of strategy and commercial development. "We are encouraged by the developments already underway by forward-thinking companies seeking to utilize new biobased materials in their products and packaging, and believe that Mirel® PHA biopolymers are functionally versatile and well poised to drive further innovation in the industry."
Earlier in 2015, Metabolix and Honeywell signed a global, exclusive technical and commercial alliance to develop PHA biopolymers for cosmetics and personal care applications.
Overview of Metabolix HBA Global 2015 Panel Presentations:
Panel Title: Natural Packaging Design That Screams Wholesome & Pure
Time: Tuesday, June 9, 2015 from 2:45 p.m. – 3:30 p.m.
Description: John Licata, Technical Service Manager at Metabolix, will participate on a panel to discuss packaging developments for natural products, including the latest options and innovations for sustainable package engineering. Mr. Licata will share relevant Metabolix developments including:
Panel Title: How to Formulate with Natural Bases & Compounds
Time: Wednesday, June 10, 2015 from 1:00 p.m. to 1:45 p.m.
Description: During this panel discussion on innovations in environmentally-friendly ingredients and natural formulation alternatives, John Licata will present relevant developments at Metabolix including its Mirel® PHA biopolymers and their use as exfoliants. This discussion is timely, as several states look to restrict the use of plastic microbeads in personal care products due to plastic accumulation in marine environments. Mr. Licata will address:
Metabolix is an innovation-driven specialty materials company focused on delivering high-performance biopolymer solutions to customers in the plastics industry. Metabolix's Mirel® biopolymers, which are derived from renewable resources, are a family of biobased performance additives and resins based on PHA (polyhodroxyalkanoates). Metabolix's proprietary biotechnology platform enables the creation of resins and compounds for use in a broad range of applications such as construction and packaging materials as well as industrial, consumer and personal care products.
For more information, please visit www.metabolix.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this press release do not constitute guarantees of future performance. Investors are cautioned that certain statements in this press release, including, without limitation, statements regarding Metabolix's expectations for market demand and Metabolix product development and similar statements, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in Metabolix's filings with the Securities and Exchange Commission. Readers are cautioned not to unduly rely on such forward-looking statements, which speak only as of the date made, when evaluating the information presented in this press release. Metabolix assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
CONTACT: Metabolix Contact: Lynne H. Brum, 617-682-4693, LBrum@metabolix.com Media Inquiries: MSLGROUP Boston Caitlin Hunt at 781-684-0770 firstname.lastname@example.orgNEXT ARTICLE
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...